Corporate Venture Seeds The Ecosystem To Grow Future Partners
This article was originally published in The Pink Sheet Daily
Executive Summary
Big pharma's venture arms are stepping in to fund early-stage companies with an eye toward increased opportunities for everyone.
You may also be interested in...
Abbott Adds Epigenetics To Its Anticancer R&D Through EpiTherapeutics Deal
Abbott broadens its approach to new cancer therapies by linking up with the Danish company EpiTherapeutics on modifying epigenetic regulation.
Abbott Adds Epigenetics To Its Anticancer R&D Through EpiTherapeutics Deal
Abbott broadens its approach to new cancer therapies by linking up with the Danish company EpiTherapeutics on modifying epigenetic regulation.
Corporate VC Funds Drive Innovation For Aileron’s Novel Stapled Peptide Technology
Aileron’s stapled peptides spark investment interest from four big pharma VC arms.